Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002369297 | SCV002666505 | uncertain significance | Hereditary cancer-predisposing syndrome | 2022-05-07 | criteria provided, single submitter | clinical testing | The p.S226G variant (also known as c.676A>G), located in coding exon 6 of the BRIP1 gene, results from an A to G substitution at nucleotide position 676. The serine at codon 226 is replaced by glycine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV004572335 | SCV005059957 | uncertain significance | Familial cancer of breast | 2023-11-12 | criteria provided, single submitter | clinical testing |